Intended for healthcare professionals
Our CompanySubscribeMy AccountLogin

A living WHO guideline on drugs for covid-19

rapid recs
rapid recs

A living WHO guideline on drugs for covid-19

WHO strongly recommends a combination of nirmatrelvir and ritonavir for patients with covid-19 at highest risk of hospital admission

Read our latest coverage of the covid-19 pandemic
SOTA figure
Novel treatments in B cell non-Hodgkin’s lymphomas

This new State of the Art review on novel treatments in B cell non-Hodgkin’s lymphomas looks at mechanisms of action, efficacy and safety, current therapeutic roles, and future directions in treatment

clinical review  |  Apr 21
Novel treatments in B cell non-Hodgkin’s lymphomas

This new State of the Art review on novel treatments in B cell non-Hodgkin’s lymphomas looks at mechanisms of action, efficacy and safety, current therapeutic roles, and future directions in treatment

SOTA figure

Latest articles

News

Ukraine conflict

UK Jobs

Glastonbury Health Centre: 6 Session Salaried GP - Glastonbury Health Centre

Current issue

latest issue
All articlesPast issues

Most read

1.

Community

Latest responses

View more

What are your thoughts?

Altmetrics

Altmetric Badge
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial: Video 1
Nov 2, 2021